A. Manaf Ali

Prof. A. Manaf Ali


Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 April 2012 in Molecules
Verified
Journal Article
Open access
PDF file
YKyih yih kok
yih yih kok
YLYang Mooi Lim
Yang Mooi Lim
KAKartini Ahmad
Kartini Ahmad
MSMohd Aspollah Sukari
Mohd Aspollah Sukari
NMNashriyah Mat
Nashriyah Mat
AAA. Manaf Ali
A. Manaf Ali
Girinimbine, a carbazole alkaloid isolated from the stem bark of Murraya koenigii was tested for the in vitro anti-tumour promoting and antioxidant activities. Anti-tumour promoting activity was determined by assaying the capability of this compound to inhibit the expression of early antigen of Epstein-Barr virus (EA-EBV) in Raji cells that was induced by the tumour promoter, phorbol 12-myristate 13-acetate. The concentration of this compound that gave an inhibition rate at fifty percent was 6.0 µg/mL and was not cytotoxic to the cells. Immunoblotting analysis of the expression of EA-EBV showed that girinimbine was able to suppress restricted early antigen (EA-R). However, diffused early antigen (EA-D) was partially suppressed when used at 32.0 µg/mL. Girinimbine exhibited a very strong antioxidant activity as compared to a-tocopherol and was able to inhibit superoxide generation in the 12-O-tetradecanoylphorbol-13-acetate (TPA)-induced differentiated premyelocytic HL-60 cells more than 95%, when treated with the compound at 5.3 and 26.3 µg/mL, respectively. However girinimbine failed to scavenge the stable diphenyl picryl hydrazyl (DPPH)-free radical.

1 January 2012 in Evidence-Based Complementary and Alternative Medicine
Verified
Journal Article
Open access
PDF file
TTT-Johari S. A. Tajudin
T-Johari S. A. Tajudin
NMNashriyah Mat
Nashriyah Mat
ASAbu Bakar Siti-Aishah
Abu Bakar Siti-Aishah
AYA. Aziz M. Yusran
A. Aziz M. Yusran
AAAfnani Alwi
Afnani Alwi
AAA. Manaf Ali
A. Manaf Ali
Methanolic extract ofCynometra cauliflorawhole fruit was assayed for cytotoxicity against the human promyelocytic leukemia HL-60 and the normal mouse fibroblast NIH/3T3 cell lines by using the MTT assay. The CD50of the extract for 72 hours was 0.9 μg/mL whereas the value for the cytotoxic drug vincristine was 0.2 μg/mL. The viability of the NIH/3T3 cells was at 80.0% when treated at 15.0 μg/mL. The extract inhibited HL-60 cell proliferation with dose dependence. AO/PI staining of HL-60 cells treated with the extract revealed that majority of cells were in the apoptotic cell death mode. Flow cytometry analysis of HL-60 cells treated at CD50of the extract showed that the early apoptotic cells were 31.0, 26.3 and 19.9% at 24, 48, and 72 hours treatment, respectively. The percentage of late apoptotic cells was increased from 62.0 at 24 hours to 64.1 and 70.2 at 48 and 72 hours, respectively. Meanwhile, percent of necrotic cells were 4.9, 6.6, and 8.5 at 24, 48, and 72 hours, respectively. This study has shown that the methanolic extract ofC. cauliflorawhole fruit was cytotoxic towards HL-60 cells and induced the cells into apoptotic cell death mode, but less cytotoxic towards NIH/3T3 cells.

1 April 2007 in Neurological Research
Verified
Journal Article
Closed access
JAJafri Malin Abdullah
Jafri Malin Abdullah
FAFarizan Ahmad
Farizan Ahmad
KAKu Asmarina Ku Ahmad
Ku Asmarina Ku Ahmad
MGMazira Mohamad Ghazali
Mazira Mohamad Ghazali
HJHasnan Jaafar
Hasnan Jaafar
FOFauziah Othman
Fauziah Othman
Brain tumorigenesis is a complex process involving multiple genetic alterations. Cyclin D1 and BAX genes are two of the most important regulators in controlling the normal proliferation and apoptosis of cells, respectively. In this study, we analysed the possibilities of involvement of cyclin D1 and BAX genes in the gliomagenesis. In determining gene alterations of exon 4 of cyclin D1 gene and exon 6 of BAX gene, all samples were amplified by polymerase chain reaction (PCR) and subsequently by direct sequencing. Our results showed a frameshift mutation (G base deletion) at nucleotide 82 of codon 28 in exon 4 of the cyclin D1 gene and another frameshift mutation with a deletion of C base at nucleotide 153 of exon 6 of the BAX gene in two separate cases of a glioblastoma multiform (WHO Grade IV) sample. These findings suggest that both cyclin D1 and BAX genes alteration are rarely found in brain tumors. However, the alteration might cause a significant effect of the normal protein production and this might contribute to the development of brain tumorigenesis in Malaysian patients.

Verified
Journal Article
Open access
PDF file
AAAied Alabsi
Aied Alabsi
SBSiti Aishah Abu Bakar
Siti Aishah Abu Bakar
RARola Ali
Rola Ali
AOAbdul Rahman Omar
Abdul Rahman Omar
MBMohd Hair Bejo
Mohd Hair Bejo
AAA. Manaf Ali
A. Manaf Ali
Newcastle disease virus (NDV) is used as an antineoplastic agent in clinical tumor therapy. It has prompted much interest as an anticancer agent because it can replicate up to 10,000 times better in human cancer cells than in most normal cells. This study was carried out to determine the oncolytic potential of NDV strain AF2240 and V4-UPM on WEHI-3B leukemia cell line. Results from MTT cytotoxicity assay showed that the CD50 values for both strains were 2 and 8 HAU for AF2240 and V4-UPM, respectively. In addition, bromodeoxyuridine (BrdU) and trypan blue dye exclusion assays showed inhibition in cell proliferation after different periods. Increase in the cellular level of caspase-3 and detection of DNA laddering using agarose gel electrophoresis on treated cells with NDV confirmed that the mode of cell death was apoptosis. In addition, flow-cytometry analysis of cellular DNA content showed that the virus caused an increase in the sub-G1 region (apoptosis peaks). In conclusion, NDV strains AF2240 and V4-UPM caused cytolytic effects against WEHI-3B leukemic cell line.

1 January 2005 in Environmental Mutagen Research
Verified
Journal Article
Open access
NRNOR FADILAH RAJAB
NOR FADILAH RAJAB
ZHZariyantey Abd. Hamid
Zariyantey Abd. Hamid
HHHunaizah Hassan
Hunaizah Hassan
AAA. Manaf Ali
A. Manaf Ali
LDLaily B. Din
Laily B. Din
SISalmaan H. Inayat-Hussain
Salmaan H. Inayat-Hussain

1 April 2008 in Hybridoma
Verified
Journal Article
Open access
SCSun Li Chong
Sun Li Chong
DMDuen Gang Mou
Duen Gang Mou
AAA. Manaf Ali
A. Manaf Ali
SLSaw Hoon Lim
Saw Hoon Lim
BTBeng Ti Tey
Beng Ti Tey
The effect of mild hypothermic (32°C) conditions on cell growth, cell-cycle progress, and antibody production of hybridoma C2E7 cells was investigated in the present study. The growth of hybridoma cells was slower during the mild hypothermic condition compared to that at 37°C; this led to about 10% decrease in maximum viable cell density and volumetric antibody productivity. However, under mild hypothermic growth conditions, the culture viability was substantially improved and the specific antibody productivity was enhanced compared to that at 37°C. The average specific productivity for the entire batch culture at 32°C is about 5% higher than that at 37°C. Cell-cycle analysis data showed that there was no growth arrestment during the mild hypothermic growth of hybridoma cells. The G1-phase cells were increased, while the S-phase cells were decreased gradually as the culture time progressed. Further analysis showed that the specific antibody productivity of hybridoma cells was correlated to the fraction of S-phase cells.